Drew Deniger
VP, Research & Development, ZIOPHARM Oncology.
Companies
- ZIOPHARM OncologyVP, Research & Development Apr 8, 2022 to Mar 17, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ZIOPHARM Oncology TCRT15,000 shares2$32.7K at $2.18Apr 8, 2022
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2